Opioid addiction is a chronic disease, generally driven by a strong and irresistible urge or craving for the intake of opioid drugs and an inability to stop despite negative consequences to health…
Treatments for opioid addiction are categorized as either substitution therapies—the opioid receptor agonists methadone, buprenorphine, and buprenorphine / naloxone combinations—or abstinence…
The most highly anticipated analgesic drugs in late-phase development belong to the anti-nerve growth factor (NGF) class: Pfizer / Eli Lilly’s tanezumab and Regeneron / Teva / Mitsubishi Tanabe…
The few currently available pharmacological treatments for opioid addiction fall into one of two categories: substitution therapies or abstinent therapies. Substitution therapies (i.e., methadone,…
Market Outlook The currently available pharmacological treatments for opioid addiction fall into one of two categories: opioid receptor agonists (i.e., methadone, buprenorphine, and buprenorphine…
The opioid addiction market is dominated by opioid receptor agonist therapies for the maintenance treatment of opioid addiction, most notably generic methadone and Indivior’s Suboxone Film. The…
The opioid addiction market is dominated by opioid receptor agonist therapies for the maintenance treatment of opioid addiction, most notably generic methadone and Indivior’s Suboxone Film. The…
The few currently available pharmacological treatments for opioid addiction fall into one of two categories: substitution therapies or abstinent therapies. Substitution therapies (i.e., methadone,…
Probing Prescriber Preferences and Payer Strategies for Current and Emerging Agents in the EU5 Nearly 800,000 individuals were diagnosed with opioid addiction in the five major European markets…
A Survey of Psychiatrists and Interviews with Payers in the EU5 Despite being a leading preventable cause of morbidity and mortality in Europe, alcohol addiction is tremendously underdiagnosed and…
How Will Physicians and Payers Value Advances in Drug Delivery? Opioid addiction is a debilitating, chronic relapsing disorder affecting nearly 5 million people in the seven major markets under…
How Will Physicians and Payers Value Advances in Drug Delivery? Opioid addiction is a debilitating, chronic relapsing disorder affecting nearly 5 million people in the seven major markets under…